Observational study · people
Follistatin-344: CSCR eye disorder in 11 bodybuilders after injection
Checked against the paper Observational studyPublished by PepVault
The takeaway
This paper links high-dose follistatin-344 injections to a fluid-under-the-retina eye condition in bodybuilders, which cleared after a single use but came back in those who injected more than once.
- Kind
- Observational study
- Studied in
- People
- Number studied
- 11
- Published
- 2020
- Journal
- Int Ophthalmol
What they tested
The team set out to describe bodybuilders who developed central serous chorioretinopathy (CSCR, fluid building up under the retina that blurs vision) after injecting high doses of follistatin-344 to gain muscle.
How the study was done
A retrospective case series, a look back at medical records, from one eye clinic. It covered 11 bodybuilding athletes who came in with worse vision after high-dose follistatin-344 injections and had eye scans (optical coherence tomography) that matched CSCR.

What they found
All 11 patients were men, with a mean age of 36.8 ± 8.1 years, and each had injected whole 1 mg vials of follistatin-344 under the skin of the belly. Most had injected a high dose only once, while a few had injected more than once. Most had CSCR in one eye at diagnosis, and one patient had it in both eyes. In every patient who had injected only once, the fluid under the retina fully cleared after an average of 2.3 ± 0.7 months and symptoms eased, while every patient who had injected more than once had CSCR come back.
What it doesn’t show
This is a small look-back series from one clinic with no comparison group, so it can't show that follistatin-344 caused CSCR or how often it happens. It only included men who already came in with vision problems.
The paper
Dağ et al. Central serous chorioretinopathy associated with high-dose follistatin-344: a retrospective case series. Int Ophthalmol. 2020.
The compound
More studies on Follistatin-344
- Follistatin-344 gene therapy: walk gains in some Becker patientsClinical trial · people · 2015
- Every study on Follistatin-344
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.